Orchard Therapeutics Plc
(NASDAQ) ORTX
Orchard Therapeutics Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$21.84M
Net Income (TTM)
$69.86M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ORTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Orchard Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
166
CEO
Bobby Gaspar, MD, PhD
Website
www.orchard-tx.comHeadquarters
London, EC4N 6EU, GB
ORTX Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
-5%
Net Income Margin
-1%
Return on Equity
-5%
Return on Capital
-20%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$4.55M
Operating Income
$31.59M
EBITDA
$8.08M
Operating Cash Flow
$75.99M
Capital Expenditure
$6.51M
Free Cash Flow
$82.50M
Cash & ST Invst.
$143.75M
Total Debt
$58.09M
Orchard Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.30M
+9.1%
Gross Profit
$4.56M
+10.3%
Gross Margin
72.31%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
166
N/A
Net Income
$35.32M
+25.7%
EBITDA
$34.62M
+26.8%
Quarterly Fundamentals
Net Cash
$77.59M
-11.9%
Accounts Receivable
$14.42M
-24.5%
Inventory
$6.64M
+184.4%
Long Term Debt
$32.84M
-25.9%
Short Term Debt
$14.98M
+6.2%
Return on Assets
-3.60%
N/A
Return on Invested Capital
-19.95%
N/A
Free Cash Flow
$24.02M
-7.3%
Operating Cash Flow
$23.89M
-33.3%